MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Subthalamic nucleus(SIN)"

  • 2017 International Congress

    Real World Clinical Outcomes Using a Novel Directional Lead from a Multicenter Registry of DBS for Parkinson’s disease

    G. Deuschl, R. Jain, H. Scholtes, K. Steinke, A. Wang, M. Pötter-Nerger, L. Timmermann, J. Volkmann, A. Kühn, P. Eldridge, J. Fitzgerald, H. Mehdorn, J. Vesper (Kiel, Germany)

    Objective: To evaluate clinical outcomes in subjects implanted with a Directional Lead for use in the treatment of levodopa-responsive Parkinson’s disease (PD) as part of…
  • 2017 International Congress

    Comparison of subthalamic and pallidal deep brain stimulation in treatment of Parkinson’s disease: a 5-year follow-up study

    A. Gamaleya, A. Tomskiy, A. Dekopov, E. Bril, A. Poddubskaya, N. Fedorova, V. Shabalov (Moscow, Russian Federation)

    Objective: To assess and compare the long-term motor and functional outcome of subthalamic (STN) and pallidal (GPi) deep brain stimulation (DBS) in treatment of patients…
  • 2017 International Congress

    INTREPID Trial: A Prospective, Double blinded, Multi-center Randomized Controlled Trial Evaluating Deep Brain Stimulation with a New Multiple-Source, Constant-Current Rechargeable System in Parkinson’s Disease

    J. Vitek, R. Jain, P. Starr (Minneapolis, MN, USA)

    Objective: The objective of the INTREPID clinical trial is to assess the improvement in motor function and quality of life in patients with advanced, levodopa-responsive…
  • 2017 International Congress

    Meta-analysis of mortality following Subthalamic and Pallidal deep brain stimulation for patients with Parkinson’s disease

    A. Negida (Zagazig, El-Sharkia, Egypt)

    Objective: The aim of this meta-analysis is to compare mortality after subthalamic (STN) and pallidal (GPi) deep brain stimulation (DBS) for patients with Parkinson's disease…
  • 2017 International Congress

    Four year outcomes of a prospective, multi-center trial evaluating Deep Brain Stimulation with a new multiple-source, constant-current rechargeable system in Parkinson’s disease

    L. Timmermann, R. Jain, N. Van Dyck, L. Chen, T. Brücke, F. Seijo, E. San Martin, V. Visser-Vandewalle, M. Barbe, S. Gill, A. Whone, M. Porta, D. Servello, F. Alesch (Cologne, Germany)

    Objective: To evaluate the four year, long-term follow up results of patients in the VANTAGE clinical study that employed multiple independent current control (MICC) Deep Brain…
  • 2017 International Congress

    The battery longevity of implantable pulse generators (IPG) in Parkinson’s disease (PD) is affected by IPG model, number of previous IPG replacements and stimulation energy delivered.

    S. Israeli-Korn, T. Fay-Karmon, S. Tessler, G. Yahalom, S. Benizri, H. Strauss, Z. Zibly, R. Spiegelmann, S. Hassin (Ramat Gan, Israel)

    Objective: To determine the effects of stimulation parameters, IPG model and the number of previous IPG replacements on IPG battery longevity. Background: For some patients rechargeable…
  • 2017 International Congress

    5-year results from the NSTAPS trial: comparing bilateral deep brain stimulation of the globus pallidus pars interna versus the subthalamic nucleus for advanced Parkinson’s disease.

    J. Boel, V. Odekerken, P. vanden Munckhof, G. Geurtsen, M. Figee, J. Dijk, R. de Haan, B. Schmand, P. Schuurman, R. de Bie (Amsterdam, Netherlands)

    Objective: Comparing motor, cognitive, and psychiatric outcome 5 years after bilateral deep brain stimulation (DBS) of the globus pallidus pars interna (GPi) and the subthalamic…
  • 2017 International Congress

    Somnolence as untoward stimulation effect in subthalamic deep brain stimulation (STN DBS) for Parkinson’s disease (PD)

    F. Danisi, C. Miller (Poughkeepsie, NY, USA)

    Objective: Excessive daytime sleepiness is a relatively common feature in PD. However, it has not been reported as a side effect of STN DBS. We…
  • 2017 International Congress

    Improvement of memory guided saccade amplitude by the STN DBS and target eccentricity

    A. YUGETA, Y. TERAO, Y. UGAWA (Tokyo, Japan)

    Objective: To investigate whether the subthalamic nucleus (STN) deep brain stimulation (DBS) improves the memory guided saccade (MGS) amplitude in the same degree in small…
  • 2017 International Congress

    Twiddler Syndrome in Deep Brain Stimulation

    N. Durmaz Celik, M. Vural, S. Ozkan (Eskişehir, Turkey)

    Objective: Twiddler syndrome is one of the major complications in DBS treatment.    Background: The patient intentionally and subconsciously spins internal pulse generator Spinning generally causes…
  • « Previous Page
  • 1
  • …
  • 24
  • 25
  • 26
  • 27
  • 28
  • …
  • 35
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley